Neuland Laboratories share news, announcements and annual reports
NSE: NEULANDLABBSE: 524558Pharmaceuticals & BiotechnologySmall Cap
Neuland Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1994 on BSE, Oct 2008 on NSE
Last close ₹19,700.00up ₹420.00 (2.18%)BSE ₹19,701.10
Share price at the NSE close on 30 Oct 2026. Previous close ₹19,280.00.
30 Oct: open ₹19,345.00, high ₹19,920.00, low ₹19,025.00
52-week range of traded prices to 30 Oct 2026
₹11,500.00Low, 23 Mar 2026₹24,225.00High, 9 Sep 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹25,275 Cr356th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 50.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 13.48
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.17%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 29.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 32.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 60,08043.6% delivered
Neuland Laboratories routine notices
178 filed, newest first. Page 4 of 4.
Dec 2020
4 Dec · Routine
Nov 2020
4 Nov · Routine
Oct 2020
20 Oct · Routine
Sep 2020
Aug 2020
14 Aug · Routine
5 Aug · Routine
Jul 2020
Jun 2020
18 Jun · Routine
16 Jun · Routine
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Apr 2019
Jan 2018
Jan 2017
Aug 2016
Jul 2016
Apr 2016
Jan 2016
Oct 2015
Jul 2015
Apr 2015
15 Apr · Routine
Trading Window for transactions in shares of the Company is closed from April 22, 2015 to May 11, 2015 (both days inclusive), inter alia, for the purpose of announcement of the Audited Financial Results by the Company for the year ended March 31, 2015.
Jan 2015
9 Jan · Routine
As per the provisions of the Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for transactions in shares of the Company is closed from January 15, 2015 to February 2, 2015 (both days inclusive), inter alia, for the purpose of announcement of the un-audited Financial Results by the Company.